Search results for "LEASING"

showing 10 items of 140 documents

La ignorada acción directa del arrendatario-usuario en el contrato de leasing

2020

En los contratos de leasing cuando el usuario resuelve la compraventa del bien arrendado por inhabilidad absoluta “aliud pro alio” se producen daños patrimoniales personales del actor. Estos daños no tienen cabida en la cesión de acciones que efectúa la sociedad de leasing. La acción directa es el único mecanismo jurídico que permite reclamar esos daños. In leasing contracts when the user resolves the sale of the leased property by absolute inability “aliud pro alio”, damages usually take place in its patrimony

leasing agreement:CIENCIAS JURÍDICAS [UNESCO]contrato de leasinglinked agreementsUNESCO::CIENCIAS JURÍDICASdirect actionacción directacesión de accionescontratos conexosdaños propiosdisposal of shares
researchProduct

Fallimento dell’utilizzatore e disciplina applicabile alla risoluzione del leasing

2021

Le Sezioni Unite della Cassazione, sollecitate da un’ordinanza di rimessione dell’anno passato, intervengono a composizione del contrasto giurisprudenziale a proposito di una questione di diritto intertemporale in materia di leasing. La Corte si pronuncia sull’individuazione della disciplina applicabile agli effetti della risoluzione del contratto a causa dell’inadempimento dell’utilizzatore, nell’ipotesi di successivo fallimento del medesimo. Il contributo ricostruisce gli orientamenti dottrinali e giurisprudenziali sul punto e si sofferma su alcuni profili problematici sollevati dalla pronuncia.

leasing risoluzione fallimento
researchProduct

Safety of human and ovine corticotropin-releasing hormone.

1986

medicine.medical_specialtyAdolescentbusiness.industryCorticotropin-Releasing HormoneGeneral MedicineCorticotropin-releasing hormoneEndocrinologyInternal medicinemedicineAnimalsHumansFemalebusinessCushing SyndromeLancet (London, England)
researchProduct

Anti-androgens for the treatment of hirsutism.

2002

Many alternatives exist for treating hirsutism. Based on an analysis of scientific literature and on the experiences of the author, the most common anti-androgen agents are discussed in this review. Androgen receptor blockers (cyproterone acetate, flutamide and spironolactone), 5 alpha-reductase inhibitors (finasteride) and androgen-suppressing agents (gonadotrophin-releasing hormone [GnRH] agonists, oestroprogestins, corticosteroids and insulin-sensitising agents) are evaluated and compared. The importance of diagnosis in choosing the most appropriate anti-androgen treatment is also discussed.

medicine.medical_specialtyCholestenone 5 alpha-ReductaseHirsutismAnti-Androgenurologic and male genital diseasesFlutamideGonadotropin-Releasing Hormonechemistry.chemical_compoundInternal medicineAndrogen Receptor AntagonistsMedicineHumansPharmacology (medical)Androgen Receptor AntagonistshirsutismPharmacologybusiness.industryCyproterone acetateAndrogen AntagonistsGeneral Medicinemedicine.diseaseAndrogen receptorEndocrinologyTreatment OutcomechemistrySpironolactoneFinasterideAndrogensFemalebusinessOxidoreductasesExpert opinion on investigational drugs
researchProduct

Human corticotropin-releasing hormone and thyrotropin-releasing hormone modulate the hypercapnic ventilatory response in humans

1996

Human corticotropin-releasing hormone (hCRH) and thyrotropin-releasing hormone (TRH) are known to stimulate ventilation after i.v. administration in humans. In a placebo-controlled, single-blind study we aimed to clarify if both peptides act by altering central chemosensitivity. Two subsequent CO2-rebreathing tests were performed in healthy young volunteers. During the first test 0.9% NaCl was given i.v.; during the second test 200 micrograms of hCRH (n = 12) or 400 micrograms of TRH (n = 6) was administered i.v. Nine subjects received 0.9% NaCl i.v. during both rebreathing manoeuvres. The CO2-response curves for the two tests were compared within the same subject. In the hCRH group a marke…

medicine.medical_specialtyCorticotropin-Releasing HormoneClinical BiochemistryThyrotropin-releasing hormonePeptide hormoneBiochemistryHypercapniaPlacebos03 medical and health sciencesCorticotropin-releasing hormone0302 clinical medicineTachycardiaInternal medicineFlushingmedicineHumansSingle-Blind MethodRespiratory systemThyrotropin-Releasing HormoneLung function030304 developmental biology0303 health sciencesbusiness.industryRespirationGeneral MedicineCarbon DioxideRespiratory Function TestsEndocrinologyBreathingbusiness030217 neurology & neurosurgeryHormoneEuropean Journal of Clinical Investigation
researchProduct

The Corticotropin‐Releasing Hormone in Neuroprotection

2011

medicine.medical_specialtyCorticotropin-releasing hormoneEndocrinologybusiness.industryInternal medicineNeurodegenerationMedicinebusinessmedicine.diseaseNeuroprotectionStress hormoneHormones in Neurodegeneration, Neuroprotection, and Neurogenesis
researchProduct

Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery

1999

Objective: To obtain information on the efficacy of repeated short cycles of GNRH agonist treatment in order to avoid hysterectomy in near-menopausal women with symptomatic fibroids. Study design: 72 pre-menopausal women (mean age 50 years) with one or more uterine fibroids >10 cm in diameter, symptomatic menorrhagia lasting three months or more and haemoglobin=9 g/dl entered the study. The patients were randomized with ratio of approximately 1:4 to: (a) immediate surgery; or (b) treatment with goserelin acetate. Patients randomized to goserelin acetate received a first cycle of 3.6 mg depot once every 28 days for four months. They were followed-up for three years. If menorrhagia was observ…

medicine.medical_specialtyFibroidsRandomizationUterine fibroidsmedicine.medical_treatmentOvariectomyHysterectomylaw.inventionGonadotropin-Releasing HormoneRandomized controlled triallawmedicineHumansFibroids; Hysterectomy; Medical treatmentMenorrhagiaGynecologyHysterectomyLeiomyomabusiness.industryGoserelinGoserelin AcetateObstetrics and GynecologyMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryMenopauseLeiomyomaReproductive MedicinePremenopauseGoserelinFemalebusinessMedical treatmentmedicine.drugHuman
researchProduct

Endocrinology and physiology of pseudocyesis

2013

This literature review on pseudocyesis or false pregnancy aims to find epidemiological, psychiatric/psychologic, gynecological and endocrine traits associated with this condition in order to propose neuroendocrine/endocrine mechanisms leading to the emergence of pseudocyetic traits. Ten women from 5 selected studies were analyzed after applying stringent criteria to discriminate between cases of true pseudocyesis (pseudocyesis vera) versus delusional, simulated or erroneous pseudocyesis. The analysis of the reviewed studies evidenced that pseudocyesis shares many endocrine traits with both polycystic ovarian syndrome and major depressive disorder, although the endocrine traits are more akin…

medicine.medical_specialtyGalactorrheaPolycystic ovarian syndromeReproductive medicinePhysiologyReviewBiologyMajor depression disorderDiagnosis DifferentialGonadotropin-Releasing HormoneEndocrinologyCatecholaminesInternal medicineHypomenorrheamedicineEndocrine systemHumansNervous System Physiological PhenomenaPseudopregnancyHypothalamus-pituitary-ovarian axisDepressive Disorder MajorObstetrics and Gynecologymedicine.diseaseEndocrinologyReproductive MedicineSympathetic nervous systemMajor depressive disorderAmenorrheaFemalemedicine.symptomFalse pregnancyHormoneDevelopmental BiologyPolycystic Ovary Syndrome
researchProduct

New Melanocortin 1 Receptor Binding Motif Based on the C-Terminal Sequence of ?-Melanocyte-Stimulating Hormone

2006

The C-terminal tripeptide of the alpha-melanocyte stimulating hormone (alpha-MSH11-13) possesses strong antiinflammatory activity without known cellular target. In order to better understand the structural requirements for function of such motif, we designed, synthesized and tested out Trp- and Tyr-containing analogues of the alpha-MSH11-13. Seven alpha-MSH11-13 analogues were synthesized and characterized for their binding to the melanocortin receptors recombinantly expressed in insect (Sf9) cells, infected with baculovirus carrying corresponding MC receptor DNA. We also tested these analogues on B16-F1 mouse melanoma cells endogenously expressing the MC1 receptor for binding and for abili…

medicine.medical_specialtyGrowth-hormone-releasing hormone receptorProtein ConformationAmino Acid MotifsMelanoma ExperimentalBiologyToxicologyBinding CompetitiveMiceThyrotropin-releasing hormone receptorInternal medicineChlorocebus aethiopsmedicineEnzyme-linked receptorAnimalsHumansACTH receptorMelanocyte-Stimulating HormonesReceptorPharmacologyGeneral MedicineMelanocortin 3 receptorCell biologyEndocrinologyCOS CellsEstrogen-related receptor gammaMelanocortinReceptor Melanocortin Type 1Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology
researchProduct

Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's Disease

1987

medicine.medical_specialtyHydrocortisoneCorticotropin-Releasing HormoneDepressionbusiness.industryGeneral MedicineCushing's diseasemedicine.diseaseCorticotropin-releasing hormoneEndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansbusinessCushing SyndromeDepression (differential diagnoses)New England Journal of Medicine
researchProduct